| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $40.5B | $35.8B | $31.9B | $30.8B | $27.7B | $6.9B | $23.9B | $21.3B |
| Cost of Revenue | $33.0B | $28.8B | $25.7B | $24.2B | $21.6B | $19.0B | $18.7B | $0.1B |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $1.8B | $1.4B | $1.1B | $1.5B | $1.6B | $0.4B | $1.3B | $1.1B |
| Net Income | $1.2B | $1.0B | $1.0B | $1.4B | $1.8B | $0.3B | $1.3B | $1.1B |
| EPS (Basic) | $3.88 | $3.16 | $3.20 | $4.36 | $5.48 | $0.94 | $3.82 | $3.13 |
| EPS (Diluted) | $3.85 | $3.14 | $3.15 | $4.29 | $5.41 | $0.93 | $3.77 | $3.10 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $30.9B | $24.4B | $22.5B | $20.5B | $22.1B | $18.0B | $16.2B | $13.5B |
| Current Assets | $13.5B | $10.0B | $9.7B | $8.5B | $10.1B | $8.8B | $7.5B | $6.8B |
| Cash & Equivalents | $1.9B | $1.1B | $1.3B | $1.3B | $2.4B | $1.9B | $1.0B | $0.8B |
| Total Liabilities | $21.3B | $15.2B | $13.5B | $11.9B | $12.7B | $10.5B | $9.9B | $8.4B |
| Current Liabilities | $12.3B | $9.3B | $8.2B | $8.2B | $8.4B | $7.1B | $6.4B | $5.8B |
| Stockholders' Equity | $8.9B | $8.4B | $8.3B | $7.9B | $8.5B | $7.1B | $6.2B | $4.9B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.6B | $1.7B | $0.5B | $1.6B | $2.4B | $1.8B | $1.2B | $1.1B |
| Investing Cash Flow | $-1.6B | $-1.5B | $-0.7B | $-0.8B | $-1.3B | $-0.3B | $-0.7B | $-0.6B |
| Capital Expenditures | — | — | — | $0.3B | $0.2B | $0.3B | $0.3B | $0.2B |
| Financing Cash Flow | $0.8B | $-0.2B | $0.2B | $-1.8B | $-0.5B | $-0.6B | $-0.3B | $-0.5B |